⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Evommune, Inc.

$10.80
+0.24 (+2.27%)

Volume:

8.374K ($90.29K)

Market Capitalization:

$391.95M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Evommune Market Segments

Regular Trading Hours

+0.14(+1.31%)
Open$10.66
Close$10.80
Low$10.66
Low Change0.00 (0.00%)
High$10.82
High Change+0.16 (+1.50%)
Range$0.16
Volume7.751K
Dollar Volume$83.71K

Premarket

+0.00(+0.00%)
Open$10.56
Close$10.56
Low$10.56
Low Change0.00 (0.00%)
High$10.56
High Change+0.00 (+0.00%)
Range$0.00
Volume623
Dollar Volume$6.58K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.16(-1.52%)
Open$10.56
Close$10.40
Low$10.40
Low Change-0.16 (-1.52%)
High$10.56
High Change+0.00 (+0.00%)
Range$0.16
Volume40.647K
Dollar Volume$422.73K

Regular Trading Hours Yesterday

+0.06(+0.57%)
Open$10.50
Close$10.56
Low$10.31
Low Change-0.19 (-1.81%)
High$11.03
High Change+0.53 (+5.05%)
Range$0.72
Volume632.64K
Dollar Volume$6.68M

Premarket Yesterday

-0.04(-0.37%)
Open$10.84
Close$10.80
Low$10.80
Low Change-0.04 (-0.37%)
High$10.84
High Change+0.00 (+0.00%)
Range$0.04
Volume325
Dollar Volume$3.51K

Evommune Top Trades

Evommune's top trade so far today returned +2.46%, while the top short trade returned -0.18%.

Evommune Moving Averages

5 Day Moving Average (SMA5)$11.76
10 Day Moving Average (SMA10)$12.32
20 Day Moving Average (SMA20)$13.22
50 Day Moving Average (SMA50)$12.76
100 Day Moving Average (SMA100)$17.66
200 Day Moving Average (SMA200)$19.79

Evommune Statistics

Average Volume (30 Days)587.01K
P/E Ratio (Current)-4.15
EPS (Current)-$2.61
Dividend Yield0.00%
Free Cash Flow-$91.10M
Cash Ratio3.43
Current Ratio11.68
Quick Ratio11.68
Debt to Equity0.00
Enterprise Value$333.81M
EV to EBITDA-3.32
EV to Sales33.38
Price to Book1.42
Price to Cash Flow
Price to Free Cash Flow
Price to Sales39.34
Return on Assets-0.31%
Return on Equity-0.34%

Evommune Stock Splits

There have been no stock splits for Evommune (EVMN).

Evommune Dividends

There have been no dividends for Evommune (EVMN).